Ferrous bisglycinate

Minzoya™ is indicated for use by females of reproductive potential to prevent pregnancy.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for: Minzoya™ is indicated for use by females of reproductive potential to prevent pregnancy.

What it is used for

Minzoya™ is indicated for use by females of reproductive potential to prevent pregnancy. Minzoya is a progestin/estrogen COC indicated for use by females of reproductive potential to prevent pregnancy.

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Ferrous bisglycinate; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/ferrous-bisglycinate
APA 7th: sofidex. (2026, August 2). Ferrous bisglycinate. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/ferrous-bisglycinate
AMA 11th: Ferrous bisglycinate. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/ferrous-bisglycinate

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.